SAREPTA THERAPEUTICS INC
Reported by Cambridge Investment Research Advisors Inc
Reported 21,000 shares, up 8,000 (61.5%) from the prior quarter.
Reported value 66.7%; share count 61.5% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2026-03-31 | 12000 |
| 2026-06-30 | 12000 |
| 2026-09-30 | 20000 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q3 2026 | Added | 21,000 | +8,000 (61.5%) | < 0.01% | $20,000 | 2026-11-02 | |
| Q2 2026 | Unchanged | 13,000 | 0 (0.0%) | < 0.01% | $12,000 | 2026-07-27 | |
| Q1 2026 | New | 13,000 | +13,000 (0.0%) | < 0.01% | $12,000 | 2026-04-30 |
Who else reported the position
23 managers reported SAREPTA THERAPEUTICS INC for Q3 2026.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | Unchanged | 52,306,000 | 0 | 1.12% | $50,344,525 | 13 qtrs |
| DeepCurrents Investment Group LLC | Unchanged | 17,245,000 | 0 | 0.47% | $16,530,776 | 2 qtrs |
| D E Shaw & Co Inc | Unchanged | 16,897,000 | 0 | < 0.01% | $16,231,408 | 6 qtrs |
| Calamos Advisors LLC | Unchanged | 15,000 | 0 | 0.04% | $14,384,550 | 13 qtrs |
| BROOKFIELD CORPORATION | New | 12,115,000 | +12,115,000 | 0.01% | $11,660,186 | 1 qtr |
| CORBYN INVESTMENT MANAGEMENT INC MD | Reduced | 10,810,000 | -67,000 | 3.09% | $10,377,153 | 3 qtrs |
| Russell Investments Group Ltd | Added | 6,036,000 | +2,861,000 | < 0.01% | $5,791,711 | 2 qtrs |
| Chicago Capital Management LLC | Added | 4,265 | +1,095 | 3.72% | $4,107,432 | 2 qtrs |
| BNP Paribas Asset Management Holding S A | Added | 3,500,000 | +3,475,346 | < 0.01% | $3,340,469 | 11 qtrs |
| FMR LLC | Unchanged | 0 | 0 | < 0.01% | $1,434,178 | 13 qtrs |
Filing details and methodology As reported
- Report period
- September 30, 2026
- Filed
- November 02, 2026
- Filing type
- 13F-HR
- Position type
- INC NOTE 1.250 9/1
Voting authority reported
No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.